Stocks to Watch: The domestic equity market is expected to open in the red on Tuesday, September 23. The GIFT NIFTY futures suggest that the NIFTY50 index will open 28 points lower.
Here is a list of stocks that may remain in focus today.
Auto stocks: Shares of automobile majors such as Maruti Suzuki India (MSIL) and Hyundai Motor India (HMIL) are expected to hog the limelight on Tuesday, September 23, as the leading carmakers on Monday saw bumper sales with buyers queuing up to buy their favourite models at lower price tags under the new GST regime.
The country's largest carmaker, Maruti Suzuki India, said its
retail sales had crossed the 25,000 mark by late evening and were expected to cross the 30,000 mark by the end of the day, as dealerships were expected to remain open till late at night.
Tata Investment Corporation: Shares of Tata Investment Corporation (TICL) are expected to trade actively on Tuesday, September 23, as the company on Monday, post-market hours, announced that it has received shareholder's approval for the stock split or subdivision of shares that it announced earlier. The company said it has fixed Tuesday, October 14, 2025, as the “Record Date” for the corporate action.
JBM Auto: Shares will be in focus as JBM Electric Vehicles (P) Ltd, part of JBM Auto Ltd and one of the leading electric bus manufacturers and EV ecosystem players, and Al Habtoor Motors, one of the UAE’s leading automobile distributors, have announced a landmark partnership to bring next-generation electric buses to the UAE market.
The agreement was formalised during a signing ceremony attended by senior leadership from both companies.
ACME Solar: ACME Solar Holdings has secured domestic funding of ₹1,100 crore for its subsidiary rated CRISIL AA- to refinance the existing debt and reduce financing costs by around 100 bps for its 300 MW renewable energy project in Rajasthan. This project has an operational track record of about six months and consistently maintains optimum CUF levels, it said.
KEC International: Shares of KEC International, a global infrastructure engineering, procurement and construction (EPC) major, are expected to be in focus on Tuesday, September 23, as the firm on Monday, after market hours, announced that it has secured the largest ever EPC order till date worth over ₹3,000 crore.
In its regulatory filing, the RPG Group company said it has secured new orders of ₹3,243 crore for Transmission & Distribution projects.
400 kV transmission lines in the United Arab Emirates (UAE);
Supply of towers, hardware and poles in the Americas.
Commenting on the order win, Vimal Kejriwal, MD & CEO, KEC International Ltd, said, "We are delighted with the new order wins in our T&D business, especially our largest ever EPC order till date. This order has further strengthened our presence in the Middle East and substantially expanded our international T&D order book."
JK Lakshmi Cement: The company said that on September 22, 2025, it commissioned the Additional Grinding Unit of 13.50 Lakh Tonnes Per Annum at Surat and also completed the de-bottlenecking of its cement mills at Jaykaypuram, Sirohi. With this, the total cement capacity of the company has increased from 16.5 MTPA to 18 MTPA.
In another announcement, JK Lakshmi Cement said it has entered into a Power Purchase Agreement and Share Purchase & Shareholders’ Agreement with Ampin C&I Power Four Private Limited for the purchase of solar power under the applicable captive power laws, and in this connection, the company has acquired a 26% equity shareholding in the said company.
RVNL: Rail Vikas Nigam Limited has emerged as the Lowest Bidder (L1) from Southern Railway for “Design, Supply, Erection, Testing & Commissioning of Traction Sub Stations (Scott-Connected).
The cost of the work order is ₹145.34 crore.
Alkem Labs: Alkem Laboratories announced the launch of Pertuza injection 420 mg/14 mL, a pertuzumab biosimilar, in India for the treatment of HER2-positive breast cancer.
Alkem’s Pertuza is an affordable, indigenously developed and manufactured biosimilar of pertuzumab. In the pivotal phase 3 clinical trial, Alkem’s pertuzumab biosimilar, developed by its biotech subsidiary, demonstrated equivalence in efficacy, safety, and immunogenicity to the reference product of the innovator.
Brigade Enterprises: Realty firm Brigade Enterprises has signed a joint development agreement (JDA) to build a residential project with a sales potential of about ₹1,200 crore.
In a regulatory filing on Monday, the company said the project, located at Banashankari, 5th Stage, south Bengaluru, will be spread over 7.5 acres.
"The project has a gross development value (GDV) of about ₹1,200 crore," it added.
Suraj Estate Developers: The company announced the launch of Suraj Park View 1, an upscale residential tower under the value luxury segment, strategically located at Shivaji Park, Dadar (West).
With an estimated Gross Development Value (GDV) of ₹250 crore and a saleable carpet area of approximately 0.53 lakh sq. ft, the project is being developed under a capital-efficient redevelopment model, leveraging Regulations 33(7), 33(7)B, and 33(12) of DCPR 2034.
Coal India: Shares of Coal India will be in focus as the PSU's arm Bharat Coking Coal Ltd (BCCL) has received SEBI's approval to launch an IPO. BCCL's issue will be entirely an offer for sale (OFS) of 46.5 crore shares by its parent state-owned Coal India Ltd (CIL), with no fresh issuance component.
Established to mine and supply high-grade coking coal, BCCL plays a critical role in powering India's steel sector, which depends heavily on its output.
With inputs from PTI
To add Upstox News as your preferred source on Google, click here.
.png)
